Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Sol Gel Technologies Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sol Gel Technologies Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Operating Income
-$11.3m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Income
$3.7B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
-1%
I
InterCure Ltd
TASE:INCR
Operating Income
â‚Ş34.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Income
-$15.1m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
S
Seach Medical Group Ltd
TASE:SEMG
Operating Income
â‚Ş4.3m
CAGR 3-Years
-23%
CAGR 5-Years
11%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Income
â‚Ş18.1m
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
2%
No Stocks Found

Sol Gel Technologies Ltd
Glance View

Market Cap
14.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
0.721 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Sol Gel Technologies Ltd's Operating Income?
Operating Income
-11.3m USD

Based on the financial report for Sep 30, 2024, Sol Gel Technologies Ltd's Operating Income amounts to -11.3m USD.

What is Sol Gel Technologies Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
18%

Over the last year, the Operating Income growth was 62%. The average annual Operating Income growth rates for Sol Gel Technologies Ltd have been 14% over the past three years , 18% over the past five years .

Back to Top